EBV-driven relapse of peripheral T-cell lymphoma, masquerading as a post transplant lymphoproliferative disorder following allo-SCT

Bone Marrow Transplant. 2014 Jan;49(1):150-2. doi: 10.1038/bmt.2013.125. Epub 2013 Aug 12.

Authors

C P Fox¹, M J Bishton¹, S O'Connor², S Hughes³, J L Byrne¹, N Russell¹

Affiliations

¹ Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
² Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
³ Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, UK.

PMID: 23933761
DOI: 10.1038/bmt.2013.125

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / therapeutic use
Diagnosis, Differential
Epstein-Barr Virus Infections / complications*
Epstein-Barr Virus Infections / diagnosis
Fatal Outcome
Genome, Viral
Graft vs Host Disease / immunology
Herpesvirus 4, Human*
Humans
Lymphatic Diseases / diagnosis
Lymphoma, T-Cell, Peripheral / complications*
Lymphoma, T-Cell, Peripheral / diagnosis
Lymphoproliferative Disorders / diagnosis*
Male
Middle Aged
Postoperative Complications
Recurrence
Stem Cell Transplantation / adverse effects
Transplantation, Homologous / adverse effects

Substances

Antineoplastic Agents